Fulcrum Therapeutics paid its 3 named executives $6.5M in total in FY2025 (Dec). CEO Alex C. Sapir was paid $3.3M of that.
Pay$100 in the stock at the end of FY22 → $155
Pay of each named executive
Alex C. SapirPresident and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Alan MussoChief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Curtis OltmansChief Legal Officer and Head of External Affairs
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.